These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35803528)

  • 1. The role of hepatic Surf4 in lipoprotein metabolism and the development of atherosclerosis in apoE
    Shen Y; Gu HM; Zhai L; Wang B; Qin S; Zhang DW
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Oct; 1867(10):159196. PubMed ID: 35803528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4.
    Wang B; Shen Y; Zhai L; Xia X; Gu HM; Wang M; Zhao Y; Chang X; Alabi A; Xing S; Deng S; Liu B; Wang G; Qin S; Zhang DW
    J Lipid Res; 2021; 62():100091. PubMed ID: 34118252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic inactivation of murine
    Tang VT; McCormick J; Xu B; Wang Y; Fang H; Wang X; Siemieniak D; Khoriaty R; Emmer BT; Chen XW; Ginsburg D
    Elife; 2022 Oct; 11():. PubMed ID: 36193893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surf4 (Surfeit Locus Protein 4) Deficiency Reduces Intestinal Lipid Absorption and Secretion and Decreases Metabolism in Mice.
    Tao G; Wang H; Shen Y; Zhai L; Liu B; Wang B; Chen W; Xing S; Chen Y; Gu HM; Qin S; Zhang DW
    Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):562-580. PubMed ID: 36756879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
    Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
    Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
    Wang Y; Tang W; Yang P; Shin H; Li Q
    Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway.
    Ying Z; van Eenige R; Beerepoot R; Boon MR; Kloosterhuis NJ; van de Sluis B; Bartelt A; Rensen PCN; Kooijman S
    Pharmacol Res; 2023 Jan; 187():106634. PubMed ID: 36574856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
    He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
    J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
    Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
    Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice.
    White EJ; Gyulay G; Lhoták Š; Szewczyk MM; Chong T; Fuller MT; Dadoo O; Fox-Robichaud AE; Austin RC; Trigatti BL; Igdoura SA
    J Biol Chem; 2018 Sep; 293(38):14689-14706. PubMed ID: 30097518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.